{"transactions":[{"id":1683347,"issuer":{"id":90076,"kind":"organization","name":"Fresh Tracks Therapeutics, Inc.","symbol":"FRTX"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"Marchio Albert N II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Restricted Stock Units","published_at":"2024-01-09T16:10:04.000Z","date":"2023-12-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0.91,"value":1137.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Prior to December 28, 2023, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of issuer common stock upon settlement. Effective on December 28, 2023, the issuer's board of directors terminated the Fresh Tracks Therapeutics, Inc. (the \"Company\") 2020 Omnibus Long-Term Incentive Plan (the \"Plan\") and all unvested RSUs granted under the Plan. The value of the terminated RSUs was replaced with a right to a cash payment valued by multiplying the number of RSUs by the closing price of the Company's common stock on such date (the \"Cash Payment\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Prior to December 28, 2023, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of issuer common stock upon settlement. Effective on December 28, 2023, the issuer's board of directors terminated the Fresh Tracks Therapeutics, Inc. (the \"Company\") 2020 Omnibus Long-Term Incentive Plan (the \"Plan\") and all unvested RSUs granted under the Plan. The value of the terminated RSUs was replaced with a right to a cash payment valued by multiplying the number of RSUs by the closing price of the Company's common stock on such date (the \"Cash Payment\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Cash Payment will vest in full on the first anniversary of the grant date of the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Cash Payment will vest in full on the first anniversary of the grant date of the RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001628280-24-000949","document":"wk-form4_1704834595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/819050/000162828024000949/wk-form4_1704834595.xml","form_type":"4"}},{"id":2045665,"issuer":{"id":90076,"kind":"organization","name":"Fresh Tracks Therapeutics, Inc.","symbol":"FRTX"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-26T18:48:48.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the first anniversary of the grant date."}],"balance_after":1250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0000819050-23-000006","document":"wf-form4_167477690143545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/819050/000081905023000006/wf-form4_167477690143545.xml","form_type":"4"}},{"id":2278489,"issuer":{"id":90076,"kind":"organization","name":"Fresh Tracks Therapeutics, Inc.","symbol":"FRTX"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-09T16:16:44.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years."}],"balance_after":30000,"derivative":{"exercise_price":0.26,"exercise_date":"2023-05-05","expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000819050-22-000046","document":"wf-form4_165212737833226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/819050/000081905022000046/wf-form4_165212737833226.xml","form_type":"4"}},{"id":2670958,"issuer":{"id":90076,"kind":"organization","name":"Fresh Tracks Therapeutics, Inc.","symbol":"FRTX"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T16:46:03.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest 25% on June 14, 2022, and the remainder will vest in equal monthly installments over the following three years."}],"balance_after":20000,"derivative":{"exercise_price":0.9,"exercise_date":"2022-06-14","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000819050-21-000090","document":"wf-form4_162370354842269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/819050/000081905021000090/wf-form4_162370354842269.xml","form_type":"4"}},{"id":3843287,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Restricted Stock Units","published_at":"2018-08-15T11:59:14.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":41666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vest."}],"balance_after":41666,"derivative":{"underlying":"Common Stock","underlying_shares":41666},"source":{"system":"sec-edgar","filing":"0001127602-18-025370","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218025370/form4.xml","form_type":"4"}},{"id":3887138,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-06-20T20:39:31.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options expire on the third anniversary of the vesting date."}],"balance_after":83334,"derivative":{"exercise_price":1.1,"underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001127602-18-021594","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218021594/form4.xml","form_type":"4"}},{"id":4014994,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-03-05T13:22:23.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 25,000 shares of Common Stock, will become exercisable on March 1, 2019, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":14.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-18-009808","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218009808/form4.xml","form_type":"4"}},{"id":4111808,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-01-03T23:50:53.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":10.1,"exercise_date":"2019-01-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-000817","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218000817/form4.xml","form_type":"4"}},{"id":4152642,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Common Stock","published_at":"2017-11-22T20:08:17.000Z","date":"2017-11-22","kind":"sale","acquired":false,"shares":3361,"price":10,"value":33610.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-17-033177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760217033177/form4.xml","form_type":"4"}},{"id":4222536,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Common Stock","published_at":"2017-08-29T21:30:53.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":2500,"price":10.42,"value":26050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.47 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3361,"source":{"system":"sec-edgar","filing":"0001127602-17-026651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760217026651/form4.xml","form_type":"4"}},{"id":4225512,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Adm Officer"}}],"security":"Common Stock","published_at":"2017-08-24T20:11:29.000Z","date":"2017-08-23","kind":"sale","acquired":false,"shares":1000,"price":10.39,"value":10390.0,"ownership":{"direct":true},"balance_after":5861,"source":{"system":"sec-edgar","filing":"0001127602-17-026402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760217026402/form4.xml","form_type":"4"}},{"id":4384426,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":92083,"kind":"person","name":"Marchio Albert N II","position":1,"cik":"0001196054","reported_name":"MARCHIO ALBERT N II","relationship":{"officer":true,"officer_title":"Chief Accounting & Ops Officer"}}],"security":"Stock Option (right To Purchase)","published_at":"2017-03-15T19:32:49.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":47500,"price":8.86,"value":420850.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 47,500 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":47500,"derivative":{"exercise_price":8.86,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001127602-17-011767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760217011767/form4.xml","form_type":"4"}}]}